U.S. Renal Care to Pay $7.3 Million to Resolve False Claims Act Allegations
U.S. Renal Care, headquartered in Plano, Texas, has agreed to pay $7.3 million to resolve allegations that Dialysis Corporation of America (DCA) violated the False Claims Act by submitting false claims to the Medicare program for more Epogen than was actually administered to dialysis patients at DCA facilities, the Justice Department announced today. U.S. Renal Care, which acquired DCA in June 2010, owns and operates more than 100 freestanding outpatient dialysis facilities throughout the United States.
Action Details
- Date:May 21, 2013
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions